159 related articles for article (PubMed ID: 2386545)
1. Sex difference in antipyrine 3-hydroxylation. An in vivo-in vitro correlation of antipyrine metabolism in two rat strains.
Buters JT; Reichen J
Biochem Pharmacol; 1990 Aug; 40(4):771-7. PubMed ID: 2386545
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of antipyrine in vivo in two rat models of liver cirrhosis. Its relationship to intrinsic clearance in vitro and microsomal membrane lipid composition.
Buters JT; Zysset T; Reichen J
Biochem Pharmacol; 1993 Sep; 46(6):983-91. PubMed ID: 8216358
[TBL] [Abstract][Full Text] [Related]
3. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of 3-methylcholanthrene and phenobarbitone treatment on the oxidative metabolism of antipyrine in vitro by microsomal fractions of rat liver.
Kahn GC; Boobis AR; Murray S; Davies DS
Xenobiotica; 1982 Aug; 12(8):509-16. PubMed ID: 7147996
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of enzyme induction on antipyrine metabolite formation.
Danhof M; Verbeek RM; van Boxtel CJ; Boeijinga JK; Breimer DD
Br J Clin Pharmacol; 1982 Mar; 13(3):379-86. PubMed ID: 7059438
[TBL] [Abstract][Full Text] [Related]
6. Influence of the genetically controlled deficiency in debrisoquine hydroxylation on antipyrine metabolite formation.
Danhof M; Idle JR; Teunissen MW; Sloan TP; Breimer DD; Smith RL
Pharmacology; 1981; 22(6):349-58. PubMed ID: 7267701
[TBL] [Abstract][Full Text] [Related]
7. The effect of age on antipyrine metabolism by liver microsomes isolated from phenobarbital-treated rats.
Henderson DJ; van Bezooijen CF
Mech Ageing Dev; 1989 Sep; 49(3):287-94. PubMed ID: 2811495
[TBL] [Abstract][Full Text] [Related]
8. Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample.
Loft S; Nielsen AJ; Borg BE; Poulsen HE
Xenobiotica; 1991 Jan; 21(1):33-46. PubMed ID: 2003365
[TBL] [Abstract][Full Text] [Related]
9. Microsomal metabolism of antipyrine in rats treated with antineoplastic drugs.
Slørdal L; Høyem-Johansen T; Aarbakke J
Pharmacology; 1983; 26(2):95-9. PubMed ID: 6844394
[TBL] [Abstract][Full Text] [Related]
10. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
Szakács T; Veres Z; Vereczkey L
Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
[TBL] [Abstract][Full Text] [Related]
11. Oxidation of R(+)- and S(-)-carvedilol by rat liver microsomes. Evidence for stereoselective oxidation and characterization of the cytochrome P450 isozymes involved.
Fujimaki M
Drug Metab Dispos; 1994; 22(5):700-8. PubMed ID: 7835220
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man.
Boobis AR; Brodie MJ; Kahn GC; Toverud EL; Blair IA; Murray S; Davies DS
Br J Clin Pharmacol; 1981 Dec; 12(6):771-7. PubMed ID: 7340879
[TBL] [Abstract][Full Text] [Related]
13. The effect of age on the oxidative metabolism of antipyrine by uninduced microsomal fractions of rat liver.
Van Geel CA; Van Bezooijen CF
Mech Ageing Dev; 1990 Apr; 53(2):169-77. PubMed ID: 2342384
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetic differences in the inhibitory effect of cimetidine on the metabolism of antipyrine.
Gachályi B; Vas A; Csillag K; Nagy B; Kocsis F; Káldor A
Eur J Clin Pharmacol; 1987; 31(5):613-5. PubMed ID: 3830247
[TBL] [Abstract][Full Text] [Related]
15. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats with a portacaval shunt.
van der Graaff M; Vermeulen NP; Joeres RP; Breimer DD
Pharmacology; 1984; 29(2):99-109. PubMed ID: 6473507
[TBL] [Abstract][Full Text] [Related]
16. The effect of malaria infection on antipyrine metabolite formation in the rat.
Mansor SM; Ward SA; Edwards G
Biochem Pharmacol; 1991 Apr; 41(8):1264-6. PubMed ID: 2009102
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of norantipyrine sulphate and norantipyrine glucuronide as major metabolites of antipyrine in man and rat.
Böttcher J; Bässmann H; Schüppel R
J Pharm Pharmacol; 1984 Jun; 36(6):391-8. PubMed ID: 6146671
[TBL] [Abstract][Full Text] [Related]
18. Influence of allylisopropylacetamide and phenobarbital treatment on in vivo antipyrine metabolite formation in rats.
Teunissen MW; Van Graft M; Vermeulen NP; Breimer DD
Xenobiotica; 1983 Aug; 13(8):497-502. PubMed ID: 6649682
[TBL] [Abstract][Full Text] [Related]
19. The effect of antipyrine and rifampin on the metabolism of diazepam.
Ohnhaus EE; Brockmeyer N; Dylewicz P; Habicht H
Clin Pharmacol Ther; 1987 Aug; 42(2):148-56. PubMed ID: 3608348
[TBL] [Abstract][Full Text] [Related]
20. Studies on in vitro antipyrine metabolism by 13C,15N double labeled method.
Nakagawa A; Nakamura K; Maeda K; Kamataki T; Kato R
Life Sci; 1987 Jul; 41(2):133-43. PubMed ID: 3298908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
